Stocks News

LAST PRICE
336.6600
TODAY'S CHANGE (%)
Trending Up3.7400 (1.1234%)

Bid / Lots
336.5000/ 2
Ask / Lots
336.8500/ 4
Open / Previous Close
337.0300 / 332.9200
Day Range
Low 334.6101
High 338.7000
52 Week Range
Low 249.7001
High 346.8500
Volume
726,955
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- Redburn Atlantic Adjusts Amgen Price Target to $200 From $180, Maintains Sell Rating, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: AMGN
  07:18 AM EDT, 09/19/2024 (MT Newswires) -- Amgen (AMGN) has an average rating of outperform and price targets ranging from $200 to $381, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from ma...
Sep 13, 2024
- AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024, from 9:00AM ET on Friday Sep 13, 2024 by PR Newswire
  9:00AM ET on Friday Sep 13, 2024 by PR Newswire
  Companies Mentioned: AMGN
  Results Illustrate Depth and Diversity of Amgen's Targeted Therapies Across Tumor Types
  Amgen(NASDAQ: AMGN) today announced the presentation of new data across its broad oncology pipeline and portfolio at the European Society for Medical Oncology (ESMO) Congress 2024, taking place Sept. 13-17 in Barcelona. The abstracts showcase data from Amgen-sponsored and investigator-sponsored studies for colorectal, lung, prostate and gastric cancers using molecularly targeted modalities.
- AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024, from 9:00AM ET on Friday Sep 13, 2024 by Dow Jones
  9:00AM ET on Friday Sep 13, 2024 by Dow Jones
  Companies Mentioned: AMGN
  
  The scientific information discussed in this news release related to our product candidates is preliminary and investigative. Such product candidates are not approved by the U.S. Food and Drug Administration, and no conclusions can or should be drawn regarding the safety or effectiveness of the product candidates. Further, any scientific information discussed in this news release relating to new indications for our products is preliminary and investigative and is not part of the labeling approved by the U.S. Food and Drug Administration for the products. The products are not approved for the investigational use(s) discussed in this news release, and no conclusions can or should be drawn regarding the safety or effectiveness of the products for these uses.
Sep 10, 2024
- Tyra Biosciences Names Doug Warner Chief Medical Officer, from 4:47PM ET on Tuesday Sep 10, 2024 by MT Newswires
  4:47PM ET on Tuesday Sep 10, 2024 by MT Newswires
  Companies Mentioned: AMGN, TYRA
  04:47 PM EDT, 09/10/2024 (MT Newswires) -- Tyra Biosciences (TYRA) said late Tuesday that it has appointed Doug Warner as its chief medical officer. The company said Warner held roles with increasing responsibility over 18 years at Amgen (AMGN). Mos...
- Update: UnitedHealth Group to Exclude AbbVie's Humira From Some US Drug Reimbursement Lists, from 2:19PM ET on Tuesday Sep 10, 2024 by MT Newswires
  2:19PM ET on Tuesday Sep 10, 2024 by MT Newswires
  Companies Mentioned: UNH, AMGN, ABBV
  02:19 PM EDT, 09/10/2024 (MT Newswires) -- (Updates with details throughout.) UnitedHealth Group (UNH) is joining other large US pharmacy benefit managers in excluding AbbVie's (ABBV) Humira from some of its lists of preferred drugs for reimbursemen...

Today
- DJ AstraZeneca PLC Stock Rises Thursday, Underperforms Market, from 2 hours ago by Dow Jones
  2 hours ago by Dow Jones
  Companies Mentioned: AZN
Yesterday
- Working to Build Next-Generation Cancer Therapies, from 1:34PM ET on Wednesday Sep 18, 2024 by Dow Jones
  1:34PM ET on Wednesday Sep 18, 2024 by Dow Jones
  Companies Mentioned: GILD
- DJ AstraZeneca PLC Stock Falls Wednesday, Outperforms Market, from 12:00PM ET on Wednesday Sep 18, 2024 by Dow Jones
  12:00PM ET on Wednesday Sep 18, 2024 by Dow Jones
  Companies Mentioned: AZN
- Bristol-Myers Squibb Says Long-Term Data Support Zeposia's Efficacy in Relapsing Multiple Sclerosis, from 8:12AM ET on Wednesday Sep 18, 2024 by MT Newswires
  8:12AM ET on Wednesday Sep 18, 2024 by MT Newswires
  Companies Mentioned: BMY
- AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment, from 7:42AM ET on Wednesday Sep 18, 2024 by MT Newswires
  7:42AM ET on Wednesday Sep 18, 2024 by MT Newswires
  Companies Mentioned: AZN
- Purple Biotech Says Pancreatic Cancer Study Data Shows CM24 With Nivolumab and Chemo Improves Survival, from 7:42AM ET on Wednesday Sep 18, 2024 by MT Newswires
  7:42AM ET on Wednesday Sep 18, 2024 by MT Newswires
  Companies Mentioned: BMY, PPBT
- FASENRA approved in the US for eosinophilic granulomatosis with polyangiitis, from 7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
  7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones
  Companies Mentioned: AZN
- New Long-Term Zeposia (ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in Relapsing Forms of Multiple Sclerosis, from 6:59AM ET on Wednesday Sep 18, 2024 by Dow Jones
  6:59AM ET on Wednesday Sep 18, 2024 by Dow Jones
  Companies Mentioned: BMY
Sep 17, 2024
- International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024, from 8:00PM ET on Tuesday Sep 17, 2024 by Dow Jones
  8:00PM ET on Tuesday Sep 17, 2024 by Dow Jones
  Companies Mentioned: FPAFY, CRRFY, KKPNY, MAKSY, REPYY, SSEZY, VIOT, AZN, IH, LOT, BLTE, YRD, EDPFY, HCM
- DJ AstraZeneca PLC Stock Falls Tuesday, Underperforms Market, from 12:00PM ET on Tuesday Sep 17, 2024 by Dow Jones
  12:00PM ET on Tuesday Sep 17, 2024 by Dow Jones
  Companies Mentioned: AZN

Amgen Inc
NASDAQ:AMGNUnited States

Search Criteria

Today

Redburn Atlantic Adjusts Amgen Price Target to $200 From $180, Maintains Sell Rating, from 7 hours ago by MT Newswires

Sep 13, 2024

AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024, from 9:00AM ET on Friday Sep 13, 2024 by PR Newswire

AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024, from 9:00AM ET on Friday Sep 13, 2024 by Dow Jones

Sep 10, 2024

Tyra Biosciences Names Doug Warner Chief Medical Officer, from 4:47PM ET on Tuesday Sep 10, 2024 by MT Newswires

Update: UnitedHealth Group to Exclude AbbVie's Humira From Some US Drug Reimbursement Lists, from 2:19PM ET on Tuesday Sep 10, 2024 by MT Newswires

Peers Headlines

Today

DJ AstraZeneca PLC Stock Rises Thursday, Underperforms Market, from 2 hours ago by Dow Jones

Yesterday

Working to Build Next-Generation Cancer Therapies, from 1:34PM ET on Wednesday Sep 18, 2024 by Dow Jones

DJ AstraZeneca PLC Stock Falls Wednesday, Outperforms Market, from 12:00PM ET on Wednesday Sep 18, 2024 by Dow Jones

Bristol-Myers Squibb Says Long-Term Data Support Zeposia's Efficacy in Relapsing Multiple Sclerosis, from 8:12AM ET on Wednesday Sep 18, 2024 by MT Newswires

AstraZeneca Says US FDA Approves Fasenra for Rare Vasculitis Treatment, from 7:42AM ET on Wednesday Sep 18, 2024 by MT Newswires

Purple Biotech Says Pancreatic Cancer Study Data Shows CM24 With Nivolumab and Chemo Improves Survival, from 7:42AM ET on Wednesday Sep 18, 2024 by MT Newswires

FASENRA approved in the US for eosinophilic granulomatosis with polyangiitis, from 7:00AM ET on Wednesday Sep 18, 2024 by Dow Jones

New Long-Term Zeposia (ozanimod) Data Demonstrate Durable Efficacy and Consistent Safety in Relapsing Forms of Multiple Sclerosis, from 6:59AM ET on Wednesday Sep 18, 2024 by Dow Jones

Sep 17, 2024

International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on September 24th and 25th, 2024, from 8:00PM ET on Tuesday Sep 17, 2024 by Dow Jones

DJ AstraZeneca PLC Stock Falls Tuesday, Underperforms Market, from 12:00PM ET on Tuesday Sep 17, 2024 by Dow Jones